XNCR
XNCR
NASDAQ · Biotechnology

Xencor Inc

$12.69
+0.76 (+6.37%)
As of May 9, 1:38 AM ET ·
Financial Highlights (FY 2026)
Revenue
119.24M
Net Income
-87,281,762
Gross Margin
Profit Margin
-73.2%
Rev Growth
-8.6%
D/E Ratio
0.19
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 60.6% 60.6%
Operating Margin -148.6% -133.8% -5.1% -5.6%
Profit Margin -73.2% -69.5% -6.3% -5.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 119.24M 130.50M 205.11M 207.84M
Gross Profit 124.21M 125.86M
Operating Income -177,243,215 -174,585,633 -10,389,491 -11,650,007
Net Income -87,281,762 -85,973,060 -12,900,416 -11,029,247
Gross Margin 60.6% 60.6%
Operating Margin -148.6% -133.8% -5.1% -5.6%
Profit Margin -73.2% -69.5% -6.3% -5.3%
Rev Growth -8.6% -8.6% +24.6% -9.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 70.91M 70.91M 77.39M 67.20M
Total Equity 376.36M 376.36M 595.63M 536.70M
D/E Ratio 0.19 0.19 0.13 0.13
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -167,331,163 -173,978,991 -15,864,221 -15,646,651
Free Cash Flow -6,278,593 -9,889,518